{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/04/02/3267157/34323/en/Roivant-Announces-Expansion-of-Brepocitinib-Development-Program-with-New-Phase-2b-3-Trial-in-Lichen-Planopilaris-LPP-and-Phase-3-Study-Results-for-Batoclimab-in-Thyroid-Eye-Disease.html", "message": "News view counter 641674 successfully enlarged"}